DESCRIPTION
Sutton, Gould, McDonnell and Beavil study the molecular mechanisms of the allergic response and in particular the structures and functions of IgE and its receptors. They have discovered that IgE is acutely bent in its Fc region, and that binding to FcεRI on mast cells involves conformational changes in both IgE and receptor. If the conformational change is inhibited, the affinity of binding can be reduced by at least 1000-fold, but even a 50-fold reduction is sufficient to cause up to 80 per cent reduction in PCA in a hFcεRI transgenic mouse model. Using knowledge of the molecular structures of IgE and FcεRI, Beavil, McDonnell and Sutton are screening for small molecule \"allosteric\" inhibitors of the IgE/ FcεRI interaction as a new approach to treatment of allergic disease. Gould is also testing anti-IgE as a treatment for non-atopic asthmatic and rhinitic patients, as well as studying the natural IgG4 \"blocking\" antibodies that are produced in response to allergens during immunotherapy. Sutton is undertaking structural studies of these IgG4 antibodies. CD23 is also a receptor for IgE. On B cells, it appears to be involved in IgE regulation, and a soluble form of CD23 further interacts with another B cell surface molecule, CD21. Gould, Sutton, McDonnell and Beavil are studying this network of interactions to understand the role of CD23 and to identify further targets for therapeutic intervention.
Gould, with Fear and Corrigan have discovered that somatic hypermutation, class switching and IgE protein synthesis occur in the nose in allergic rhinitis and airways of both atopic and non-atopic asthmatics, suggesting that anti-IgE strategies may be beneficial in both groups of patients. Gould discovered that VH5 is over-represented in the nasal allergenic IgE response suggesting that a superantigen, such as the S. aureus enterotoxins, may play a role in the pathogenesis of allergic disease. They are also cloning and expressing whole IgE antibodies, as well as the corresponding scFv fragments, specific for grass pollen allergens and S. aureus superantigens for functional analysis of the IgE molecules, and crystal structure determination of the Fv-allergen/superantigen complexes (Sutton). An MRC Programme grant was awarded to Sutton, Gould and Beavil in 2006 to support this research, which has been renewed in 2011 to include additional collaborations with McDonnell and Lack to study the IgE and IgG4 response to peanut allergens.
Gould and Fear have also shown that both the germline IgE epsilon and IgG gamma chain genes are constitutively expressed (revealing open chromatin structure) in nearly all naïve B cells, disproving a long held dogma that IL-4 stimulates switching to IgE in B cells by causing the unfolding of chromatin structure in the region of the IgE epsilon heavy-chain gene. They have also studied the mechanism of DNA recombination events associated with class-switching, using ultra-high resolution microscopy.
Cousins, Lavender and Lee have been studying the mechanism of T cell differentiation using both transcriptomic and epigenetic analysis, this work has revealed the identity of a number of cell-type specific transcripts and begun to show that this differential gene expression is facilitated by establishment of cell type specific chromatin environments and expression of non-coding RNA transcripts that are likely to be involved in maintaining transcriptional competence of loci during lineage commitment. Similar work is being undertaked on Airway smooth muscle cells, to establish whether altered expression of both mRNAs and microRNAs in muscle from people with asthma is influenced by altered chromatin environments at these genes. A second objective of these studies is to identify the histone modifying enzymes responsible for the establishment of these chromatin environments.
With Susan John, Lavender and Cousins have demonstrated a role for STAT5 in transcriptional regulation of the transcription factor c-Maf and shown regulation of expression of this factor by the IL-2 pathway.
Associated research programmes
Associated staff research interests
Interests:
Biophysics; Allergy; Asthma; IgE structure and function; Fluorescent Biosensors.
Email:
Website:
Interests:
Research interests: Structure of IgE and its receptors; molecular mechanisms of allergy; inhibitor design; antibody structure in allergy and auto-immune disease; antibiotic resistance enzymes; enzyme mechanism and protein engineering. Research techniques: X-ray crystallography, NMR and other biophysical techniques. Member of the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma; leader of Centre Programme in IgE Structure, Function and Regulation. Head of Structural Biology, Randall Division of Cell and Molecular Biophysics.
Tel:
020 7848 6423
Fax:
020 7848 6410
Email:
Website:
Interests:
I am currently researching the molecular mechanisms regulating immunoglobulin heavy chain class switch recombination and the role chromatin structure plays in its regulation. In particular I am focusing on mechanisms that drive switching towards IgE; the isotype involved in asthma and allergy.
Tel:
0207 188 0613
Fax:
0207 403 8643
Email:
Website:
Interests:
Hannah Gould is Professor of Biophysics and is one of the four principal investigators in the Allergy and Asthma Group in the Randall Division of Cell and Molecular Biophysics. She is also a principal investigator in the Asthma, Allergy and Lung Biology, and the MRC Centre in Allergic Mechanisms of Asthma. Her research is focused on the biology of IgE and the basis of allergic disease. She has a very active group who work on a diverse range of topics, extending from 'molecules to the bedside'. With Professors Brian Sutton and Jim McDonnell and Dr Andrew Beavil, she collaborates in studies of the relation of the structure to function of IgE and its receptors FcepsilonRI and CD23. With clinical collaborators, Professors Christopher Corrigan, Gideon Lack, Stephen Durham and others in the MRC Centre in Allergic Mechanisms of Asthma, she collaborates on problems relating to allergic mechanisms in rhinitis and asthma. With Dr David Fear in the Division of Asthma , Allergy and Lung Biology, she collaborates on chromatin remodelling in the regulation of IgE synthesis; her main contribution is single cell imaging of immunoglobulin genes by in situ hybridisation and proteins by immunofluoresence in class switch recombination, using confocal microscopy. Local germinal centre reactions (comprising somatic hypermutation, class switch recombination, and receptor revision) in allergic inflammation, is a passionate interest. She participates in the design and execution of two current clinical trials, one on the efficacy of an anti-IgE in the treatment of non-atopic asthma and the other on IgE immunotherapy of ovarian cancer. She collaborates with scientists in the US, France, and Belgium
References:
1. IgE in allergy and asthma today, H.J. Gould & B.J. Sutton, Nature Reveiws in Immunology, 8, 205-217, 2008
2. Germinal-centre reactions in allergic inflammation. Trends in Immunology 27, 446-452, 2006
Tel:
020 7848 6442
Email:
Website: